NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+0.75%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.34B
AUM Growth
+$1.34B
(-8.4%)
Cap. Flow
-$69M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
26.37%
Holding
218
New
22
Increased
46
Reduced
51
Closed
31
Top Buys
| 1 |
Immunocore
IMCR
|
$26.4M |
| 2 |
Sarepta Therapeutics
SRPT
|
$22.8M |
| 3 |
BWX Technologies
BWXT
|
$17.8M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$17M |
| 5 |
Immunovant
IMVT
|
$14.5M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$37.8M |
| 2 |
Inspire Medical Systems
INSP
|
$37.4M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$35.7M |
| 4 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$19.3M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$17.2M |
Sector Composition
| 1 | Healthcare | 52.08% |
| 2 | Technology | 13.86% |
| 3 | Industrials | 8.87% |
| 4 | Energy | 5.36% |
| 5 | Financials | 5.26% |
